EXPRESIÓN DE RECEPTORES A DOPAMINA EN POBLACIONES ACTIVADAS CD4+ CD8+, CD19+ Y CD11C+ POSTERIOR AL TRATAMIENTO CON PRAMIPEXOL IMPLICACIONES PARA LA ENFERMEDAD DE PARKINSON

Edwin Jafet Gallegos Altamirano; Erandi Pérez Figueroa; Laura Adalid-Peralta

EXPRESSION OF DOPAMINE RECEPTORS IN ACTIVATED CD4+ CD8+, CD19+ AND CD11C+ POPULATIONS AFTER TREATMENT WITH PRAMIPEXOL IMPLICATIONS FOR PARKINSON'S DISEASE

Authors

Edwin Jafet Gallegos Altamirano Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez
Erandi Pérez Figueroa Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez
Laura Adalid-Peralta Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez

Keywords:

1. Parkinson's disease 2. Dopamine Agonists 3. Immune cells.

Additional Files

Published

2024-04-23

How to Cite

Gallegos Altamirano, E. J., Pérez Figueroa, E., & Adalid-Peralta, L. (2024). EXPRESSION OF DOPAMINE RECEPTORS IN ACTIVATED CD4+ CD8+, CD19+ AND CD11C+ POPULATIONS AFTER TREATMENT WITH PRAMIPEXOL IMPLICATIONS FOR PARKINSON’S DISEASE. Archivos De Neurociencias, 29(S1). Retrieved from https://archivosdeneurociencias.org/index.php/ADN/article/view/576

Download Citation

Issue

Vol. 29 No. S1 (2024): Annual Research Meeting from the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez

Section

Conference proceedings

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.